Gufic Biosciences Share Price Target 2026: Expert Forecast, Catalysts and Key Risks
- May 12, 2026
- Posted by: Neeraj Pandey
- Category: News
The Gufic Biosciences share price target for 2026 stands at Rs 460 as per analyst forecast implying 20 to 40 percent upside from the current market price of Rs 380. Investors tracking the Gufic Biosciences share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Gufic Biosciences share price target thesis updated April 2026.
Click Here Get Free Investment Predictions on Univest
Track live Gufic Biosciences price, FII/DII flows and analyst targets on the Univest Screener.
Gufic Biosciences Company Overview
Tap to Access Best Research Pieces on Univest
Gufic Biosciences (NSE: GUFICBIO) is a listed company in India’s Pharmaceuticals Branded Injectables sector with a market capitalisation of Rs 2,800 crore. At CMP Rs 380 against a 52 week range of Rs 280 to Rs 560, the stock currently offers meaningful upside to the analyst forecast Gufic Biosciences share price target of Rs 460. For more share price target analysis, visit Univest Blogs.
| Parameter | Value |
|---|---|
| NSE Ticker | GUFICBIO |
| Sector | Pharmaceuticals Branded Injectables |
| CMP April 2026 | Rs 380 |
| 52 Week High | Rs 560 |
| 52 Week Low | Rs 280 |
| Market Cap | Rs 2,800 crore |
| Trailing P/E | 30x |
| 12M Analyst Target | Rs 460 |
| Bull Case Target | Rs 591 |
| Bear Case Target | Rs 276 |
Why Is Gufic Biosciences Share Price Target Set at Rs 460 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the year where analysts expect Gufic Biosciences to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 380 and the Gufic Biosciences share price target 2026 of Rs 460. Analysts project 15 to 20 percent PAT growth in FY27. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Gufic Biosciences share price target forecast. Track Q4 results live on the Univest Screener.
Structural Sector Tailwinds in Pharmaceuticals Branded Injectables
India’s Pharmaceuticals Branded Injectables sector is expanding at 12 to 18 percent annually driven by urbanisation, rising incomes, government policy continuity, and the broad India growth narrative. Gufic Biosciences’s market position within this expanding sector creates compounding runway that directly supports the Gufic Biosciences share price target forecast of Rs 460. Discover top stocks on the Univest Screener.
RBI Rate Cut Cycle and Improving Macro Backdrop
India’s RBI rate cut cycle which commenced in 2026 reduces Gufic Biosciences’s borrowing costs and stimulates end customer demand. Lower interest rates improve EBITDA to PAT conversion, directly expanding EPS and supporting the Gufic Biosciences share price target 2026 of Rs 460. Compare Gufic Biosciences with sector peers live on the Univest Screener.
Union Budget 2026 Policy Support
Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, continued PLI scheme support, and consumption demand incentives create a positive policy backdrop for Gufic Biosciences’s Pharmaceuticals Branded Injectables business, directly supporting the Gufic Biosciences share price target 2026 bull case.
Improving FII Flows Post US Tariff Shock
As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Gufic Biosciences share price target of Rs 460. Track live FII/DII activity on the Univest Screener.
Gufic Biosciences Share Price Targets Short Term 12 Month and Long Term
Download the Univest iOS App or Univest Android App to get daily stock recommendations and SEBI registered research.
Short Term Gufic Biosciences Share Price Target 3 to 6 Months
The short term Gufic Biosciences share price target is anchored to the 52 week low support zone near Rs 280. Subscribe to Univest Pro for SEBI registered entry, target, and stop loss recommendations on Gufic Biosciences.
12 Month Gufic Biosciences Share Price Target 2026
The 12 month analyst forecast Gufic Biosciences share price target 2026 is Rs 460 implying 20 to 40 percent upside from CMP Rs 380. Track live targets on the Univest Screener.
Long Term Gufic Biosciences Share Price Target FY27 to FY28
For investors with a 2 to 3 year horizon, the long term Gufic Biosciences share price target is Rs 591 in the bull case. For more analysis, visit Univest Blogs.
Bull Case and Bear Case for Gufic Biosciences Share Price Target
Bull Case Gufic Biosciences Share Price Target Rs 591
The bull case for the Gufic Biosciences share price target of Rs 591 materialises if FY27 earnings exceed forecast and the Pharmaceuticals Branded Injectables sector benefits from a broad FII driven re-rating. Discover top stocks and live analyst targets on the Univest Screener.
Bear Case Gufic Biosciences Share Price Target Rs 276
The bear case sees the Gufic Biosciences share price target testing Rs 276 if FY27 guidance disappoints significantly and FII outflows from India persist. Track support levels on the Univest Screener.
| Scenario | Price Target | Conditions |
|---|---|---|
| Bull Case | Rs 591 | FY27 beat, macro normalisation, sector re-rating, strong FII inflows |
| Base Case Forecast | Rs 460 | In line FY27 earnings, tariff resolution, FII recovery to neutral |
| Bear Case | Rs 276 | FY27 guidance cut, persistent FII outflows, sector de-rating |
Key Risks to the Gufic Biosciences Share Price Target 2026
US Tariff Macro Headwind
The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across all Indian equities including Gufic Biosciences. This is the key downside risk to the Gufic Biosciences share price target 2026 forecast of Rs 460. Monitor trade developments live on the Univest Screener.
Valuation and Earnings Miss Risk
At 30x P/E, Gufic Biosciences is priced for consistent execution. Any earnings miss or guidance cut creates disproportionate de-rating risk, the most immediate risk to the Gufic Biosciences share price target 2026 of Rs 460. Track earnings on the Univest Screener.
Competitive Pressure in Pharmaceuticals Branded Injectables
Intensifying competition in Pharmaceuticals Branded Injectables may compress Gufic Biosciences’s pricing power and market share over the medium term. Subscribe to Univest Pro for SEBI registered research on Gufic Biosciences.
FII Selling Pressure and Currency Risk
Global risk off events can trigger institutional selling, disconnecting price from fundamental value. Track live FII/DII flows on the Univest Screener.
How to Invest in Gufic Biosciences
- Research on Univest Screener: Search GUFICBIO at univest.in/screeners for live fundamentals and the latest Gufic Biosciences share price target data.
- Open a Demat Account: Buy Gufic Biosciences (GUFICBIO) through any SEBI registered broker. Start on Univest here.
- Plan Your Entry: Key support near Rs 280. First resistance at the lower bound of the Gufic Biosciences share price target range of Rs 460.
- Position Sizing: Allocate maximum 3 to 5 percent of your portfolio to any single stock.
- Monitor: Download the Univest App for SEBI registered analyst research alerts on the Gufic Biosciences share price target.
FAQs on Gufic Biosciences Share Price Target 2026
What is the Gufic Biosciences share price target for 2026?
The Gufic Biosciences share price target 2026 is Rs 460 based on analyst forecast. Bull case is Rs 591, bear case is Rs 276. Track live on the Univest Screener.
Is Gufic Biosciences a good buy at CMP Rs 380?
At Rs 380, Gufic Biosciences offers potential upside to the Gufic Biosciences share price target 2026 of Rs 460. Depends on your risk tolerance and horizon. Get free research on Univest.
What are the main risks to the Gufic Biosciences share price target?
Key risks to the Gufic Biosciences share price target of Rs 460 include US tariff macro headwinds, valuation at 30x P/E, competitive dynamics in Pharmaceuticals Branded Injectables, and FII selling. Track on the Univest Screener.
What are the key catalysts for the Gufic Biosciences share price target?
Primary catalysts for the Gufic Biosciences share price target 2026 include Q4 FY26 results with positive FY27 guidance, RBI rate cuts, Union Budget policy support, and FII flow recovery. Track live on the Univest Screener.
What is the Gufic Biosciences share price target for 2027?
For FY27 to FY28, analysts project the Gufic Biosciences share price target toward Rs 591 in the bull case. Consult a SEBI registered financial advisor.
Where can I track Gufic Biosciences live analyst targets?
Track the Gufic Biosciences share price target live at univest.in/screeners. Download the Univest Android App or Univest iOS App.
What is Gufic Biosciences 52 week high and low?
Gufic Biosciences’s 52 week high is Rs 560 and 52 week low is Rs 280. The current CMP of Rs 380 offers potential upside to the analyst forecast Gufic Biosciences share price target 2026 of Rs 460.
How to buy Gufic Biosciences shares?
Buy Gufic Biosciences (GUFICBIO) through any SEBI registered broker on NSE. Research the Gufic Biosciences share price target on the Univest Screener and download the Univest App for SEBI registered analyst research alerts.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
